Constellation Pharmaceuticals has been granted a patent for novel compounds useful in treating diseases related to methyl modifying enzymes. The patent covers pharmaceutical compositions and methods for treating such conditions. GlobalData’s report on Constellation Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Constellation Pharmaceuticals, was a key innovation area identified from patents.
The granted patent (Publication Number: US11919912B2) discloses a compound of a specific chemical formula, along with various derivatives and configurations. The compound is designed for potential use in pharmaceutical compositions for treating cancer. The patent claims cover different variations of the compound, including specific substitutions and stereochemical configurations, highlighting the versatility and potential applications of the disclosed compound.
Furthermore, the patent also includes a method for treating cancer in a subject by administering an effective amount of the compound or its pharmaceutically acceptable salt. The method specifically mentions a wide range of cancers that can be targeted using the disclosed compound, such as breast cancer, prostate cancer, colon cancer, and various others. This demonstrates the broad spectrum of potential applications for the compound in the field of oncology, showcasing its versatility and effectiveness in combating different types of cancer.
To know more about GlobalData’s detailed insights on Constellation Pharmaceuticals, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
